期刊文献+

高效液相色谱法测定人红细胞中6-甲基巯基嘌呤核糖核苷酸的浓度 被引量:1

Determination of the concentrations of 6-methylmercaptopurine ribonucleotides(6-MMPR) in human red blood cells by HPLC
原文传递
导出
摘要 目的:建立测定人红细胞6-甲基巯基嘌呤核糖核苷酸(6-MMPR)浓度的高效液相色谱法。方法:红细胞首先经70%高氯酸沉淀蛋白,并在酸性条件下100℃加热45min,6-MMPR水解生成6-甲基巯嘌呤(6MMP)后进样分析。以6-MMP定量分析6MMPR浓度。色谱柱为HypersilGOLDC1H柱(4.6mm×250mm,5gm),检测波长290nm,柱温35℃;流动相为0.02mol·L“磷酸钾缓冲液(pH3.3)乙腈(95:5);流速0.9mL.min-1.结果:红细胞中6-MMP在80.91~3236.36pmol.(8×10-8)-1。红细胞浓度范围内线性关系良好(r2=0.9985),最低定量浓度为80.91pmol·(8×10^8)-1。红细胞。日内及日间RSD分别小于2.09%,5.61%,方法回收率为100.27%~110.79%,平均提取回收率大于70%。结论:该法操作简便快速、灵敏、专属性强,可应用于患者服用硫唑嘌呤后红细胞6一MMPR浓度的测定。 OBJECTIVE To establish an HPLC method for the determination of 6-methylmercaptopurine ribonucleotides (6- MMPR) in human red blood cells (RBC). METHODS The RBC samples were deproteinated by 70% perehloric acid. 6-MM- PR were hydrolyzed to 6-methylmercaptopurine (6 MMP) by heating the sample for 45 rain at 100 ℃. Separation was achieved by Hypersil GOLD Clscolumn (4. 6 mm× 250 mm, 5 ptm) with UV detection at 290 nm. The mobile phase consisted of 0. 02 mol.L-1 potassium phosphate buffer (pH 3. 3) : acetonitrile (95:5). RESULTS The calibration curve was linear over the range of 80. 91 -3 236. 36 pmol- (8 × 10^8 ) -1 RBC 02 = 0. 998 5) and the limit of quantitation was 80. 91 pmol. (8 × 10^8 )- 1 RBC; The intra-and inter-day coefficients of variation were less than 2. 09% and 5.61%, respectively. The mean analytical recoveries were 100. 27% - 110. 79%, and the mean extraction recoveries were more than 70%. CONCLUSION This method is simple, rapid, sensitive and specific, and it enables quantitation of 6-MMPR in RBC from patients under AZA therapy.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2011年第9期719-722,共4页 Chinese Journal of Hospital Pharmacy
基金 湖北省自然科学基金(编号:2009CDB380)
关键词 6-甲基巯基嘌呤核糖核苷酸 6-甲基巯嘌呤 高效液相色谱法 6-methylmercaptopurine ribonucleotides 6 methylmercaptopurine HPLC
  • 相关文献

参考文献9

  • 1Sahasranaman S, Howard D, Roy S. Clinical pharmacology and pharmacogenetics of thiopurines[J]. Eur J Clin Pharmacol, 2008,64(8) : 753-767.
  • 2Coulthard S, Hogarth L. The thiopurines: an update[J]. In- vest New Drugs, 2005,23(6) :523-532.
  • 3Derijks LJ, Wong DR. Pharmacogenetics of thiopurines in in- flammatory bowel disease[J]. Curr Pharm Des, 2010,16(2):145-154.
  • 4Vogt MH, Stet EH, de Abreu RA, et al. The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me- MPR) cytotoxicity in Molt F4 human malignant T-lympho- blasts[J].Biochim Biophys Acta, 1993,1181 (2) : 189-194.
  • 5Dubinsky MC, Lamothe S, Yang HY, et al. Pharmaeogenom- ics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease[J]. Gastroenterology, 2000, 118(4):705- 713.
  • 6Dubinsky MC, Yang H, Hassard PV, et al. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease[J]. Gastroenter- ology, 2002,122(4) :904-915.
  • 7Dervieux T, Boulieu R. Simultaneous determination of 6-thio- guanine and 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC[J]. Clin Chem, 1998, 44(3) : 551- 555.
  • 8Lennard L, Singleton HJ. High-performance liquid chromato- graphic assay of the methyl and nucleotide metabolites of 6- mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6 methylmercaptopurine metabolites in a single sample[J]. J Chromatogr, 1992, 583 ( 1 ) : 83-90.
  • 9Dervieux T, Meyer G, Barham R, et al. Liquid chromatogra- phy-tandem mass spectrometry analysis of erythroeyte thiopu- rine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathio- prine/6-mercaptopurine therapy [J].Clin Chem, 2005, 51 ( 11 ) : 2074-2084.

同被引文献17

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部